Treatment options for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections
ZHANG Chi1,2, LING Baodong1,2
1. Small Molecule Drugs Key Laboratory of Sichuan Province, Institute of Materia Medica, Chengdu Medical College, Chengdu 610500, China; 2. Non-coding RNA and Drug Discovery Laboratory, Chengdu Medical College, Chengdu 610500, China
Abstract：Acinetobacter baumannii (A. baumannii) is the major pathogen causing nosocomial infectious diseases in the world due to various intrinsic and acquired mechanisms of drug resistance. There are no effective treatments for the infections caused by multidrug-resistant A. baumannii and extensively-resistant A. baumannii. This review lists standard drugs and new options for the treatment.